neoplasms

Documents about neoplasms

• More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery#805079ClinicalTrials.gov
• PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors#843077ClinicalTrials.gov
• A Study of LY4257496 in Participants With Cancer (OMNIRAY)#828238ClinicalTrials.gov
• Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer#208474ClinicalTrials.gov
• Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)#836884ClinicalTrials.gov
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)#844803ClinicalTrials.gov
• Intended Use Study of the BD SurePath Plus™ Pap#800704ClinicalTrials.gov
• High Dose Somatostatin Analogues in Neuroendocrine Tumors#804846ClinicalTrials.gov
• Early Intervention Strategies for Lung Cancer#833718ClinicalTrials.gov
• Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma#143539ClinicalTrials.gov
• Breath Test for Early Detection of Lung Cancer#806397ClinicalTrials.gov
• A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b#806970ClinicalTrials.gov
• Imaging Study for FdCyd and THU Cancer Treatment#842727ClinicalTrials.gov
• A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer#837059ClinicalTrials.gov
• SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I#842893ClinicalTrials.gov
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab#839044ClinicalTrials.gov
• Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage#801880ClinicalTrials.gov
• Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer#807575ClinicalTrials.gov
• M7824 Related Adverse Effects in Adults With Cancer#287535ClinicalTrials.gov
• Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms#307305ClinicalTrials.gov
• Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms#390922ClinicalTrials.gov
• Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer#287557ClinicalTrials.gov
• Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture#827095ClinicalTrials.gov
• BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities#848741ClinicalTrials.gov
• Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.#195309ClinicalTrials.gov
• Use of Fluorescein Dye for the Removal of Brain Tumors#844288ClinicalTrials.gov
• Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer#67876ClinicalTrials.gov
• Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.#801813ClinicalTrials.gov
• LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer#846073ClinicalTrials.gov
• Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients#825729ClinicalTrials.gov
• Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer#640563ClinicalTrials.gov
• Selinexor Monotherapy for Cytoreduction in BCR::ABL1-Negative Myeloproliferative Neoplasms#840019ClinicalTrials.gov
• A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis#841721ClinicalTrials.gov
• HR Versus RFA for HCC in Patients With PHT#141115ClinicalTrials.gov
• Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies#398314ClinicalTrials.gov
• A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer#845860ClinicalTrials.gov
• Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer#847806ClinicalTrials.gov
• Biomarker Analysis of Central Nervous System Tumors#810857ClinicalTrials.gov
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers#842351ClinicalTrials.gov
• Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma#800182ClinicalTrials.gov
• A Study of Ultrasonography With Elastography in Skin Neoplasms#810284ClinicalTrials.gov
• Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease#839625ClinicalTrials.gov
• Tranexamic Acid During Upper GI Endoscopic Resection Procedures#838529ClinicalTrials.gov
• A Trial for Patients With Advanced/Recurrent Cervical Cancer#830015ClinicalTrials.gov
• A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms#136418ClinicalTrials.gov
• Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy#807052ClinicalTrials.gov
• EPO906 Therapy in Patients With Advanced Colorectal Cancer#810908ClinicalTrials.gov
• Alemtuzumab and Pentostatin In T-cell Neoplasms#810935ClinicalTrials.gov
• Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer#121848HAL (France)
• Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence#843616ClinicalTrials.gov

Related topics